June 16, 2026, 1 pm ET/10 am PT
Thanks to emerging technologies, researchers are shifting away from animal studies when modeling disease. Compared to animal models, human-based new-approach methodologies (NAMs), such as spheroids, organoids, tissue chips, and other sophisticated cell culture models, can often better recapitulate disease with greater complexities and higher throughputs. Additionally, scientists can develop NAMs from patient samples, which facilitates the understanding of human variability and supports personalized medicine.
In this webinar, scientists will discuss various human cell-based NAMs for endometrial cancer, glioblastoma, and more, focusing on their ability to accurately model disease in a high-throughput manner.
Topics to be covered in this webinar:
- A first-of-its-kind, patient-derived endometrial cancer organoid platform, developed to better understand how these cancers evade the immune system
- A 3D glioma blood-brain barrier model for high throughput testing of tumoricidal capability
- A combined immune cell migration and immune cell killing assay for immuno-oncology models
Offered Free by: Corning | Biocompare
See All Resources from: Corning | Biocompare
